Noxxon Pharma AG has appointed Aram Mangasarian as chief business officer, with responsibility for the corporate and business development activities of the company.
Dr Mangasarian previously worked for Novexel, a French anti-infectives company which was recent acquired by AstraZeneca.
Noxxon is an early stage platform company with mirror-image oligonucleotide therapeutics called Spiegelmers.
Copyright 2010 Evernow Publishing Ltd